Skip to content

AcrySof® IQ PanOptix® Toric Trifocal IOL TFNT30 (REF TFNT30U255)Recalls & reported problems

Alcon Laboratories, Inc. · AcrySof® IQ PanOptix® Toric Trifocal intraocular lenses (IOLs) are ultraviolet absorbing and blue light filtering foldable multifocal IOLs · Class 3 · Implant

All models of AcrySof IQ PanOptix Toric Trifocal IOL (165)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00380652415637), received between Jul 5, 2022 and Jul 5, 2022 — classified as 1 injury.

The most frequently reported specific device problem is “Optical Decentration” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Optical Decentration1

Patient problems

  • Blurred Vision1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 5, 2022Optical Decentration; Optical Decentration

    A HEALTHCARE PROFESSIONAL REPORTED THE PATIENT COMPLAINED OF DECREASED VISION FOLLOWING AN INTRAOCULAR LENS IMPLANT PROCEDURE, IT WAS NOTICED THAT THE IOL WAS DECENTERED 1.5MM RELATIVE TO THE VISUAL AXIS. THE ACTUAL LENS WAS EXCHANGED IN A SECONDARY PROCEDURE. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: Blurred Vision

    MAUDE report 14916097 ↗

Other Lens, multifocal intraocular devices

All Lens, multifocal intraocular devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page